4.7 Article

Carvedilol is associated with improved survival in patients with cirrhosis: a long-term follow-up study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

Beta-blockers in cirrhosis: Evidence-based indications and limitations

Susana G. Rodrigues et al.

JHEP REPORTS (2020)

Review Medicine, General & Internal

Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis- Literature Review

Abdulrahman Ismaiel et al.

FRONTIERS IN MEDICINE (2019)

Review Gastroenterology & Hepatology

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease

Brandon J. Perumpail et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Review Cardiac & Cardiovascular Systems

Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol)

James J. DiNicolantonio et al.

AMERICAN JOURNAL OF CARDIOLOGY (2013)

Article Gastroenterology & Hepatology

Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding

Pavel Drastich et al.

ANNALS OF HEPATOLOGY (2011)

Editorial Material Gastroenterology & Hepatology

Carvedilol for Portal Hypertension in Patients with Cirrhosis

Jaime Bosch

HEPATOLOGY (2010)

Article Medicine, Research & Experimental

Protective antioxidant effects of carvedilol in a rat model of ischaemia-reperfusion injury

H Akbas et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2005)

Article Medicine, General & Internal

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial

GL Bakris et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)